Indeed, this suppressive immunophenotype correlated with tumor PD-L1 can be evaluated by endobronchial ultrasound-guided transbronchial needle aspiration before immune therapy [29] (Fig. 2A). This evidence concerns the gene CD274 and neoplasm.